Oxidative stress and status of antioxidant enzymes in children with Kashin-Beck disease

Osteoarthritis and Cartilage

Volumn 21, Issue 11, 2013, Pages 1781-1789

  Wang, W ^a   Wei, S ^b   Luo, M ^a   Yu, B ^a   Cao, J ^a   Yang, Z ^a   Wang, Z ^a   Goldring, M B ^c   Chen, J ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b YAN'AN UNIVERSITY   (China)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Antioxidant enzyme; Cartilage; Kashin Beck disease; Oxidative stress; T AOC

Indexed keywords

4 HYDROXYNONENAL; ANTIOXIDANT; PROTEOGLYCAN; REACTIVE OXYGEN METABOLITE; SELENIUM; THIOBARBITURIC ACID REACTIVE SUBSTANCE; 4-HYDROXY-2-NONENAL; 8-OXO-7-HYDRODEOXYGUANOSINE; ALDEHYDE; DEOXYGUANOSINE; THIOBARBITURIC ACID; THIOBARBITURIC ACID DERIVATIVE;

ARTICLE; ARTICULAR CARTILAGE; BONE NECROSIS; CARTILAGE CELL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KASHIN BECK DISEASE; MALE; OXIDATIVE STRESS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; CHEMISTRY; HAIR; LIPID PEROXIDATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ALDEHYDES; ANTIOXIDANTS; CARTILAGE, ARTICULAR; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHONDROCYTES; DEOXYGUANOSINE; FEMALE; HAIR; HUMANS; KASHIN-BECK DISEASE; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PROTEOGLYCANS; SELENIUM; THIOBARBITURATES;

EID: 84884987641     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.08.002     Document Type: Article

References (43)

1. Malaisse F., Mathieu F. Big Bone Disease. A Multidisciplinary Approach of KBD in Tibet Autonomous Region (P.R. China) 2008, vol. 15:70-78. LesPresses Agronomiques de Gembloux, ASBL Belgium.
2. Mathieu F., Begaux F., Lan Z.Y., Suetents C., Hinsenkamp M. Clinical manifestations of Kashin-Beck disease in NyemoValley, Tibet. Int Orthop 1997, 21:151-156.
3. Voshchenko A.V., Ivanov V.N. Kashin-Beck disease in the USSR. Proceedings of International Workshop on Kashin-Beck Disease and Non-communicable Diseases 1990, 152-196. World Health Organization.
4. Guo X., Zhang S., Mo D. The role of low selenium occurrence of Kashin-Beck disease. JXJTU (Med Sci) 1992, 4:99-108.
5. Duan C., Guo X., Zhang X., Yu H., Yan H., Gao Y., et al. Comparative analysis of gene expression profiles between primary knee osteoarthritis and an osteoarthritis endemic to Northwestern China, Kashin-Beck disease. Arthritis Rheum 2010, 62(3):771-780.
6. Pasteels J.L., Liu F.D., Hinsenkamp M., Rooze M., Mathieu F., Perlmutter N. Histology of Kashin-Beck lesions. Int Orthop 2001, 25:151-153.
7. Chen J.H., Xue S., Li S., Wang Z.L., Yang H., Wang W., et al. Oxidant damage in Kashin-Beck disease and a rat Kashin-Beck disease model by employing T-2 toxin treatment under selenium deficient conditions. JOrthop Res 2012, 31:1229-1237.
8. Allander E. Kashin-Beck disease. An analysis of research and public health activities based on a bibliography 1849-1992. Scand J Rheumatol (Suppl) 1994, 99:1-36.
9. Cao J., Li S., Shi Z., Sun J., Yue Y., Chen J., et al. Articular cartilage metabolism in patients with Kashin Beck disease: an endemic osteoarthropathy in China. Osteoarthritis Cartilage 2008, 6:680-688.
10. Henrotin Y.E., Bruckner P., Pujol J.P. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 2003, 11:747-755.
11. Ostalowska A., Birkner Assist E., MWiecha M.A. Lipid peroxidation and antioxidant enzymes in synovial fl{ligature}uid of patients with primary and secondary osteoarthritis of the knee joint. Osteoarthritis Cartilage 2006, 14:139-145.
12. Sarbana S., Kocyigitb A., Yazar M. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 2005, 38:981-986.
13. Kobayashi M., Squire G.R., Mousa A., Tanzer M., Zukor D.J., Antoniou J., et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 2005, 52:128-135.
14. Mohtai M., Gupta M.K., Donlon B., Ellison B., Cooke J., Gibbons G., et al. Expression of interleukin-6 in osteoarthritic chondrocytes and effects of fluid-induced shear on this expression in normal human chondrocytes invitro. JOrthop Res 1996, 14:67-73.
15. Tetlow L.C., Adlam D.J., Woolley D.E. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 2001, 44:585-594.
16. Feldmann M., Brennan F.M., Foxwell B.M., Maini R.N. The role of TNF alpha and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun 2001, 3:188-199.
17. Grigolo B., Roseti L., Fiorini M., Facchini A. Enhanced lipid peroxidation in synoviocytes from patients with osteoarthritis. JRheumatol 2003, 30(2):345-347.
18. Zhu J., Yue Z., Wang J. Oxidative DNA damage of cartilage in osteoarthrosis. Hunan Yi Ke Da Xue Xue Bao 1998, 23(5):438-440.
19. Jikimoto T., Nishikubo Y., Koshiba M., Kanagawa S., Morinobu S., Morinobu A., et al. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol Immunol 2001, 38:765-772.
20. Biniecka M., Kennedy A., Fearon U., Ng C.T., Veale D.J., O'Sullivan J.N. Oxidative damage in synovial tissue is associated with invivo hypoxic status in the arthritic joint. Ann Rheum Dis 2010, 69(6):1172-1178.
21. Monboisse J.C., Borel J.P. Oxidative damage to collagen. EXS 1992, 62:323-327.
22. Klamfeldt A., Marklund S. Enhanced breakdown invitro of bovine articular cartilage proteoglycans by conditional synovial medium: the effect of superoxide dismutase and catalase. Scand J Rheumatol 1987, 6:41-45.
23. Burkhardt H., Schwingel M., Menninger H., Macartney H.W., Tschesche H. Oxygen radicals as effectors of cartilage destruction: direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis Rheum 1986, 29:379-387.
24. Lander H.M., Hajjar D.P., Hempstead B.L., Mirza U.A., Chait B.T., Campbell S., et al. Amolecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. JBiol Chem 1997, 272(7):4323-4326.
25. Kurz B., Lemke A., Kehn M., Domm C., Patwari P., Frank E.H., et al. Influence of tissue maturation and antioxidants on the apoptotic response of articular cartilage after injurious compression. Arthritis Rheum 2004, 50:123-130.
26. Wang G.Y., Zhou R.H., Sun S.Z. Methods of fluorimetric determination of trace amount of selenium in biological material, water and soil. Acta Nutr Sinica 1985, 7:39-41.
27. Hafeman D.G., Sunde R.A., Hoekstra W.G. Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. JNutr 1974, 104:580-587.
28. Sun Y., Oberley L.W., Li Y.A. Asimple method for clinical assay of superoxidedismutase. Clin Chem 1988, 34:497-500.
29. Benzie I.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996, 239:70-76.
30. Goth L. Asimple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 1991, 196:143-151.
31. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
32. Henrotin Y., Kurz B., Aigner T. Oxygen and reactive oxygen species in cartilage degradation: friends or foes?. Osteoarthritis Cartilage 2005, 13:643-654.
33. Yudoh K., Nguyen T., Nakamura H., Hongo-Masuko K., Kato T., Nishioka K. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther 2005, 7(2):R380-R391.
34. Cillero-Pastor B., Carames B., Lires-Dean M., Vaamonde-Garcia C., Blanco F.J., Lopez-Armada M.J. Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Arthritis Rheum 2008, 58(8):2409-2419.
35. Petersen S.V., Oury T.D., Ostergaard L., Valnickova Z., Wegrzyn J., Thøgersen I.B., et al. Extracellular superoxide dismutase (EC-SOD) binds to type i collagen and protects against oxidative fragmentation. JBiol Chem 2004, 279:13705-13710.
36. Henrotin Y., Kurz B. Antioxidant to treat osteoarthritis: dream or reality?. Curr Drug Targets 2007, 8(2):347-357.
37. Grishko V.I., Ho R., Wilson G.L., Pearsall A.W. Diminished mitochondrial DNA integrity and repair capacity in OA chondrocytes. Osteoarthritis Cartilage 2009, 17(1):107-113.
38. Regan E., Flannelly J., Bowler R., Tran K., Nicks M., Carbone B.D., et al. Extracellular superoxide dismutase and oxidant damage in osteoarthritis. Arthritis Rheum 2005, 52(11):3479-3491.
39. Aigner T., Fundel K., Saas J., Gebhard P.M., Haag J., Weiss T., et al. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum 2006, 54(11):3533-3544.
40. Ruiz-Romero C., Calamia V., Mateos J., Carreira V., Martinez-Gomariz M., Fernandez M., et al. Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance. Mol Cell Proteomics 2009, 8(1):172-189.
41. Olszewska-Slonina D.M., Matewski D., Drewa G., Wozniak A., Czajkowski R., Rajewski P., et al. Oxidative equilibrium in the prophylaxis of degenerative joint changes: an analysis of pre- and postoperative activity of antioxidant enzymes in patients with hip and knee osteoarthritis. Med Sci Monit Poland 2010, 16:238-245.
42. Wang Z. Review on studies of Kashin-Beck disease in China. Chin J Endem Dis 2007, 26:15-20.
43. Wang W., Guo X., Chen J., Xu P., Lammi M.J. Morphology and phenotype expression of types I, II, III, and X collagen and MMP-13 of chondrocytes cultured from articular cartilage of Kashin-Beck disease. JRheumatol 2008, 5(4):696-702.